Sandbox chemo1: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
|||
| (6 intermediate revisions by one other user not shown) | |||
| Line 85: | Line 85: | ||
* [[Topotecan|Topotecan (Hycamtin)]] | * [[Topotecan|Topotecan (Hycamtin)]] | ||
====== | ====== Anthracyclines ====== | ||
* [[Bleomycin|Bleomycin (Blenoxane)]] | * [[Bleomycin|Bleomycin (Blenoxane)]] | ||
* [[Dactinomycin|Dactinomycin (Cosmegen)]] | * [[Dactinomycin|Dactinomycin (Cosmegen)]] | ||
| Line 151: | Line 151: | ||
===== Monoclonal antibodies ===== | ===== Monoclonal antibodies ===== | ||
* [[ | ====== Anti-CD20 antibodies ====== | ||
* [[Rituximab|Rituximab (Rituxan)]] | |||
* [[Ibritumomab|Ibritumomab (Zevalin)]] | * [[Ibritumomab|Ibritumomab (Zevalin)]] | ||
* [[Obinutuzumab|Obinutuzumab (Gazyva)]] | * [[Obinutuzumab|Obinutuzumab (Gazyva)]] | ||
* [[Ofatumumab|Ofatumumab (Arzerra)]] | * [[Ofatumumab|Ofatumumab (Arzerra)]] | ||
====== Anti-CD30 antibodies ====== | ====== Anti-CD30 antibodies ====== | ||
*[[Brentuximab|Brentuximab (Adcetris)]] | * [[Brentuximab|Brentuximab (Adcetris)]] | ||
====== Anti-CD33 antibodies ====== | ====== Anti-CD33 antibodies ====== | ||
| Line 171: | Line 166: | ||
====== Anti-CD52 antibodies ====== | ====== Anti-CD52 antibodies ====== | ||
* [[Alemtuzumab|Alemtuzumab (Campath)]] | * [[Alemtuzumab|Alemtuzumab (Campath)]] | ||
====== Anti-CTLA–4 antibodies ====== | |||
* [[Ipilimumab|Ipilimumab (Yervoy)]] | |||
====== Anti-EGFR (ErbB1) antibodies ====== | ====== Anti-EGFR (ErbB1) antibodies ====== | ||
| Line 176: | Line 174: | ||
* [[Panitumumab|Panitumumab (Vectibix)]] | * [[Panitumumab|Panitumumab (Vectibix)]] | ||
===== Anti-HER2/neu (ErbB2) antibodies ===== | ====== Anti-PD–1 antibodies ====== | ||
*[[Ado-trastuzumab emtansine|Ado-trastuzumab emtansine (Kadcyla)]] | * [[Nivolumab |Nivolumab (Opdivo)]] | ||
*[[Trastuzumab|Trastuzumab (Herceptin)]] | * [[Pembrolizumab|Pembrolizumab (Keytruda)]] | ||
====== Anti-HER2/neu (ErbB2) antibodies ====== | |||
* [[Ado-trastuzumab emtansine|Ado-trastuzumab emtansine (Kadcyla)]] | |||
* [[Trastuzumab|Trastuzumab (Herceptin)]] | |||
====== Anti-VEGF antibodies ====== | ====== Anti-VEGF antibodies ====== | ||
| Line 188: | Line 190: | ||
===== IL-6 inhibitors ===== | ===== IL-6 inhibitors ===== | ||
*[[Siltuximab|Siltuximab (Sylvant)]] | * [[Siltuximab|Siltuximab (Sylvant)]] | ||
===== Immunotherapy ===== | ===== Immunotherapy ===== | ||
*[[Interferon alfa-2b|Interferon alfa-2b (Intron A)]] | * [[Interferon alfa-2b|Interferon alfa-2b (Intron A)]] | ||
---- | ---- | ||
| Line 198: | Line 200: | ||
===== Erythrocyte growth factors ===== | ===== Erythrocyte growth factors ===== | ||
*[[Erythropoietin|Erythropoietin (Procrit)]] | * [[Erythropoietin|Erythropoietin (Procrit)]] | ||
===== Granulocyte growth factors ===== | ===== Granulocyte growth factors ===== | ||
*[[Filgrastim|Filgrastim (Granix)]] | * [[Filgrastim|Filgrastim (Granix)]] | ||
*[[Sargramostim|Sargramostin (Leukine)]] | * [[Sargramostim|Sargramostin (Leukine)]] | ||
*[[Tbo-filgrastim|Tbo-filgrastim (Granix)]] | * [[Tbo-filgrastim|Tbo-filgrastim (Granix)]] | ||
===== Megakaryocyte growth factors ===== | ===== Megakaryocyte growth factors ===== | ||
| Line 210: | Line 212: | ||
---- | ---- | ||
=== Supportive Medications === | |||
===== Chemotherapy protective agents ===== | ===== Chemotherapy protective agents ===== | ||
*[[Amifostine|Amifostine (Ethyol)]] | * [[Amifostine|Amifostine (Ethyol)]] | ||
*[[Cyanocobalamin|Cyanocobalamin]] | * [[Cyanocobalamin|Cyanocobalamin]] | ||
*[[Dexrazoxane|Dexrazoxane (Zinecard)]] | * [[Dexrazoxane|Dexrazoxane (Zinecard)]] | ||
*[[Folinic acid|Folinic acid (Leucovorin)]] | * [[Folinic acid|Folinic acid (Leucovorin)]] | ||
*[[Glucarpidase|Glucarpidase (Voraxaze)]] | * [[Glucarpidase|Glucarpidase (Voraxaze)]] | ||
*[[Levoleucovorin|Levoleucovorin (Fusilev)]] | * [[Levoleucovorin|Levoleucovorin (Fusilev)]] | ||
*[[Mesna|Mesna (Mesnex)]] | * [[Mesna|Mesna (Mesnex)]] | ||
===== Antiemetic agents ===== | ===== Antiemetic agents ===== | ||
*[[Netupitant and palonosetron |Netupitant and palonosetron (Akynzeo)]] | * [[Netupitant and palonosetron |Netupitant and palonosetron (Akynzeo)]] | ||
===== RANK ligand inhibitors ===== | ===== RANK ligand inhibitors ===== | ||
| Line 229: | Line 231: | ||
---- | ---- | ||
=== Miscellaneous === | |||
===== | ===== Mitotic inhibitors ===== | ||
* [[Eribulin|Eribulin (Halaven)]] | * [[Eribulin|Eribulin (Halaven)]] | ||
* [[Ixabepilone|Ixabepilone (Ixempra)]] | * [[Ixabepilone|Ixabepilone (Ixempra)]] | ||
===== | ===== Bisphosphonates ===== | ||
* [[Zoledronic Acid|Zoledronic Acid (Zometa)]] | * [[Zoledronic Acid|Zoledronic Acid (Zometa)]] | ||
| Line 277: | Line 279: | ||
* [[Radium-223 chloride|Radium-223 chloride (Xofigo)]] | * [[Radium-223 chloride|Radium-223 chloride (Xofigo)]] | ||
===== Somatostatin | ===== Somatostatin analogs ===== | ||
* [[Octreotide|Octreotide (Octreotide)]] | * [[Octreotide|Octreotide (Octreotide)]] | ||
Latest revision as of 18:00, 25 February 2015
Chemotherapeutic Agents by Category
Alkylating agents
Nitrogen mustards
- Chlorambucil (Leukeran)
- Cyclophosphamide (Cytoxan)
- Ifosfamide (Iflex)
- Melphalan (Alkeran)
- Mechlorethamine (Mustargen)
Ethylenimines
Methylhydrazines
Alkylsulfonates
Nitrosoureas
Triazenes
Platinum coordination complexes
Antimetabolites
Folic acid analogs
Pyrimidine analogs
- Azacytidine (Vidaza)
- Capecitabine (Xeloda)
- Cytarabine (Cytosar)
- Floxuridine (FUDR)
- Fluorouracil (Adrucil, Efudex)
- Gemcitabine (Gemzar)
Purine analogs
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Fludarabine (Fludara)
- Mercaptopurine (Purinethol)
- Nelarabine (Arranon)
- Pentostatin (Nipent)
- Thioguanine (Tabloid)
Ribonucleotide reductase inhibitors
Natural products
Vinca alkaloids
- Vinblastine (Velban, Velsar)
- Vincristine (Oncovin, Vincasar)
- Vincristine liposome (Marqibo)
- Vinorelbine (Navelbine)
Taxanes
Epipodophyllotoxins
Camptothecins
Anthracyclines
- Bleomycin (Blenoxane)
- Dactinomycin (Cosmegen)
- Daunorubicin (Daunoxome)
- Doxorubicin (Adriamycin, Rubex)
- Epirubicin (Ellence)
- Idarubicin (Idamycin)
- Mitomycin C (Mutamycin)
- Mitoxantrone (Novantrone)
- Valrubicin (Valstar)
Antineoplastic enzymes
Hormones and Antagonists
Adrenocortical suppressants
Adrenocortico-steroids
Progestins
Anti-estrogens
Aromatase inhibitors
Androgens
Anti-androgens
- Abiraterone (Zytiga)
- Bicalutamide (Casodex)
- Dutasteride (Avodart)
- Enzalutamide (Xtandi)
- Flutamide (Eulexin)
- Finasteride (Proscar)
- Ketoconazole (Nizoral)
- Nilutamide (Nilandron)
- Triptorelin (Trelstar)
GnRH agonists
GnRH antagonists
Biologics
Monoclonal antibodies
Anti-CD20 antibodies
Anti-CD30 antibodies
Anti-CD33 antibodies
Anti-CD52 antibodies
Anti-CTLA–4 antibodies
Anti-EGFR (ErbB1) antibodies
Anti-PD–1 antibodies
Anti-HER2/neu (ErbB2) antibodies
Anti-VEGF antibodies
IL-2 inhibitors
IL-6 inhibitors
Immunotherapy
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
- Amifostine (Ethyol)
- Cyanocobalamin
- Dexrazoxane (Zinecard)
- Folinic acid (Leucovorin)
- Glucarpidase (Voraxaze)
- Levoleucovorin (Fusilev)
- Mesna (Mesnex)
Antiemetic agents
RANK ligand inhibitors
Miscellaneous
Mitotic inhibitors
Bisphosphonates
HDAC inhibitors
Hedgehog pathway inhibitors
Immunomodulatory drugs (IMiDs)
Kinase inhibitors
- Afatinib (Gliotrif)
- Cabozantinib (Cometriq)
- Crizotinib (Xalkori)
- Dasatinib (Sprycel)
- Erlotinib (Tarceva)
- Gefitinib (Iressa)
- Ibrutinib (Imbruvica)
- Idelalisib (Zydelig)
- Lapatinib (Tykerb)
- Nilotinib (Tasigna)
- Palbociclib (Ibrance)
- Sorafenib (Nexavar)
- Sunitinib (Sutent)